United States - English - NLM (National Library of Medicine)

natural story co.,ltd. - undaria pinnatifida (unii: icv1ok7m1s) (undaria pinnatifida - unii:icv1ok7m1s), hydrolyzed glycosaminoglycans (bovine; 50000 mw) (unii: 997385v0vv) (hydrolyzed glycosaminoglycans (bovine; 50000 mw) - unii:997385v0vv) - special skincare for dry and sensitive skin with abundant moisture and sea algae extract apply proper amount to the skin

Malta - English - Medicines Authority

c & m marketing limited 3 ferdinando inglott street, attard atd 3134, malta - potassium glycerophosphate, sodium glycerophosphate, calcium glycerophosphate - oral liquid - potassium glycerophosphate 45.6 mg/ml sodium glycerophosphate 22.8 mg/ml calcium glycerophosphate 45.6 mg/ml - vitamins

Malta - English - Medicines Authority

c & m marketing limited 3 ferdinando inglott street, attard atd 3134, malta - paracetamol, caffeine, codeine phosphate - film-coated tablet - paracetamol 500 mg caffeine 30 mg codeine phosphate 8 mg - analgesics

Canada - English - Health Canada

glaxosmithkline inc - urea; hydrocortisone acetate - cream - 10%; 1% - urea 10%; hydrocortisone acetate 1% - anti-inflammatory agents

Canada - English - Health Canada

glaxosmithkline inc - hydrocortisone acetate; urea - lotion - 1%; 10% - hydrocortisone acetate 1%; urea 10% - anti-inflammatory agents

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 200 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate; pregelatinised maize starch; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 100 mg - tablet, film coated - excipient ingredients: magnesium stearate; pregelatinised maize starch; sodium starch glycollate; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; sodium starch glycollate; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - topiramate, quantity: 25 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate; microcrystalline cellulose; pregelatinised maize starch; lactose monohydrate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - epilepsy: topiramate is indicated in adults and children 2 years and over: - as monotherapy in patients with newly diagnosed epilepsy, - for conversion to monotherapy in patients with epilepsy, and - as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome. migraine: topiramate is indicated for the prophylaxis of migraine headache in adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - topiramate, quantity: 25 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; purified water; industrial methylated spirit; ammonia - epilepsy. adults and children 2 years and over: as monotherapy in patients with newly diagnosed epilepsy;. for conversion to monotherapy in patients with epilepsy;as add-on therapy in partial onset seizures (with or without secondary generalised seizures), primary generalised tonic-clonic seizures or drop attacks associated with lennox-gastaut syndrome.. migraine. prophylaxis of migraine headache in adults.